European Journal of Cancer
Volume 43, Issue 14 , Pages 2074-2081, September 2007

Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumours

  • F. Pein

      Affiliations

    • Institut Regional du Cancer Nantes Atlantique, Dept de Recherche Therapeutique, CLCC Rene Gauducheau, Nantes, France
  • ,
  • R. Pinkerton

      Affiliations

    • Queensland Childrens Cancer Centre, Royal Childrens and Mater Childrens Hospitals, Brisbane, Queensland 4101, Australia
    • Corresponding Author InformationCorresponding author: Tel.: +617 3840 3424; fax: +617 3840 8012.
  • ,
  • P. Berthaud

      Affiliations

    • Novartis Pharma, Basel, Switzerland
  • ,
  • K. Pritchard-Jones

      Affiliations

    • Department of Paediatrics, Royal Marsden NHS Trust and Institute of Cancer Research, Downs Road, Sutton, United Kingdom
  • ,
  • G. Dick

      Affiliations

    • Department of Paediatrics, Royal Marsden NHS Trust and Institute of Cancer Research, Downs Road, Sutton, United Kingdom
  • ,
  • G. Vassal

      Affiliations

    • Institut Gustave Roussy, Department of Paediatric and Adolescent Oncology and UPRES-EA-2710, Parmacology and New Cancer Therapies, Villejuif, France

Received 3 October 2006; received in revised form 25 June 2007; accepted 4 July 2007. published online 23 August 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(07)00526-6

doi:10.1016/j.ejca.2007.07.003

European Journal of Cancer
Volume 43, Issue 14 , Pages 2074-2081, September 2007